Open AccessVentricular repolarization indexes in patients treated with hydroxychloroquine – azithromycin combination for COVID-19
Author(s) -
Şeyda Günay,
Serhat Çalışkan,
Deniz Sığırlı,
Emre Sahin
Publication year - 2020
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2020_134
Subject(s) - qt interval , hydroxychloroquine , medicine , azithromycin , cardiology , torsades de pointes , repolarization , covid-19 , disease , infectious disease (medical specialty) , biology , electrophysiology , antibiotics , microbiology and biotechnology
Combination of hydroxychloroquine and azithromycin for the treatment of coronavirus disease 2019 (COVID-19) carries increased risk of corrected QT (QTc) prolongation and cardiac arrhythmias.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom